Free Trial

IGC Pharma (IGC) Earnings Date, Estimates & Call Transcripts

$0.38 +0.01 (+2.99%)
(As of 12/20/2024 ET)

IGC Pharma Latest Earnings Summary

Latest
Earnings Date
Nov. 12Estimated
Actual EPS
(Nov. 12)
-$0.02 Beat By $0.01
Consensus EPS
(Nov. 12)
-$0.03

IGC Pharma released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.02, which topped analysts' consensus estimates of -$0.03 by $0.01. Quarterly revenue was reported to be $0.41 million, above analyst estimates of $0.29 million. With a trailing EPS of -$0.18, IGC Pharma's earnings are expected to grow next year, from ($0.13) to ($0.12) per share.

Get IGC Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGC Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IGC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IGC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IGC Pharma Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.13) EPS
Next Year EPS Consensus Estimate: ($0.12) EPS

IGC Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$0.03-$0.02+$0.01-$0.02$0.29M$0.41M

IGC Pharma Earnings - Frequently Asked Questions

IGC Pharma (NYSEMKT:IGC) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on IGC's earnings history.

In the previous quarter, IGC Pharma (NYSEMKT:IGC) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.01. Learn more on analysts' earnings estimate vs. IGC's actual earnings.

IGC Pharma (NYSEMKT:IGC) has a recorded annual revenue of $1.18 million.

IGC Pharma (NYSEMKT:IGC) has a recorded net income of -$13 million. IGC has generated -$0.18 earnings per share over the last four quarters.

IGC Pharma's earnings are expected to grow from ($0.13) per share to ($0.12) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSEMKT:IGC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners